Drupal.behaviors.print = function(context) {window.print();window.close();}>
In Suit, Aria Says Sequenom 'Misrepresents' Scope of Patent for Noninvasive Prenatal Testing
December 21, 2011
In Suit, Aria Says Sequenom 'Misrepresents' Scope of Patent for Noninvasive Prenatal Testing
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Verinata Health Sues Sequenom Over Prenatal Diagnostic Patent Rights
February 29, 2012 / Clinical Sequencing News
Sequenom Runs More Than 13K T21 Tests in Q2; Plans to Expand Capacity in US and Overseas
August 1, 2012 / Clinical Sequencing News
As Rivals Vie for Share of Noninvasive Trisomy Testing Market, Physicians See Value for Screening
July 3, 2012 / Clinical Sequencing News
Sequenom Sees Steady Growth of MaterniT21 Test Despite Competition
June 6, 2012 / Clinical Sequencing News
Sequenom Plans Sample-Prep Automation, Increased Multiplexing to Double MaterniT21 Capacity
May 9, 2012 / Clinical Sequencing News